Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Nanotechnology for Delivery of Gemcitabine to Treat Pancreatic Cancer Publisher Pubmed



Birhanu G1, 2 ; Javar HA3 ; Seyedjafari E4 ; Zandikarimi A4
Authors

Source: Biomedicine and Pharmacotherapy Published:2017


Abstract

Pancreatic cancer (PC) is one of the most deadly and quickly fatal human cancers with a 5-year mortality rate close to 100%. Its prognosis is very poor, mainly because of its hostile biological behavior and late onset of symptoms for clinical diagnosis; these bring limitations on therapeutic interventions. Factors contributing for the difficulties in treating PC include: high rate of drug resistance, fast metastasis to different organs, poor prognosis and relapse of the tumor after therapy. After being approved by US FDA 1997, Gemcitabine (Gem) is the first line and the gold standard drug for all stages of advanced PC till now. However, its efficacy is unsatisfactory, mainly due to; its chemical instability and poor cellular uptake, resulting in an extremely short half-life and low bioavailability. To solve this drawbacks and increase the therapeutic outcome important progress has been achieved in the field of nanotechnology and offers a promising and effective alternative. This review mainly focus on the most commonly investigated nanoparticle (NP) delivery systems of Gem for PC treatment and the latest progresses achieved. Novel nanocarriers with better tumor targeting efficiencies and maximum treatment outcome to treat this deadly due are given much attention. © 2017 Elsevier Masson SAS
Related Docs
View other Related Docs
1. The Potential Role of Chitosan-Based Nanoparticles As Drug Delivery Systems in Pancreatic Cancer, IUBMB Life (2020)
2. Nanoparticles and Targeted Drug Delivery in Cancer Therapy, Immunology Letters (2017)
3. In Vivo Drug Delivery of Gemcitabine With Pegylated Single-Walled Carbon Nanotubes, Materials Science and Engineering C (2016)
Experts (# of related papers)
View all Related Experts
Fatemeh Atyabi (4)
Rassoul Dinarvand (3)
Other Related Docs
4. The Use of Nanoparticles As a Promising Therapeutic Approach in Cancer Immunotherapy, Artificial Cells# Nanomedicine and Biotechnology (2016)
5. Influence of Peg Molecular Weight on the Drug Release and in Vitro Cytotoxicity of Single-Walled Carbon Nanotubes-Peg-Gemcitabine Conjugates, Current Drug Delivery (2016)
6. Clinical Applications of Nanomedicine in Cancer Therapy, Drug Discovery Today (2020)
7. Folate-Conjugated Nanoparticles As a Potent Therapeutic Approach in Targeted Cancer Therapy, Tumor Biology (2015)
8. Micelle-Based Nanoparticles With Stimuli-Responsive Properties for Drug Delivery, Nanotechnology Reviews (2024)
9. Application of Nano-Based Systems for Drug Delivery and Targeting: A Review, Journal of Nanoparticle Research (2020)
10. Synergistic Effect of Self-Assembled Curcumin and Piperine Co-Loaded Human Serum Albumin Nanoparticles on Suppressing Cancer Cells, Drug Development and Industrial Pharmacy (2020)
11. Therapeutic Efficacy of Cisplatin Thermosensitive Liposomes Upon Mild Hyperthermia in C26 Tumor Bearing Balb/C Mice, Molecular Pharmaceutics (2017)
12. Codelivery of Hydrophobic and Hydrophilic Drugs by Graphene-Decorated Magnetic Dendrimers, Langmuir (2018)
13. Design and Fabrication of Dual-Targeted Delivery System Based on Gemcitabine-Conjugated Human Serum Albumin Nanoparticles, Chemical Biology and Drug Design (2020)
14. Albumin Nanostructures As Advanced Drug Delivery Systems, Expert Opinion on Drug Delivery (2016)
15. Nexus Between in Silico and in Vivo Models to Enhance Clinical Translation of Nanomedicine, Nano Today (2021)
16. Nanoparticles in Cancer Immunotherapies: An Innovative Strategy, Biotechnology Progress (2021)
17. Smart Internal Stimulus-Responsive Nanocarriers for Drug and Gene Delivery, Smart internal stimulus-responsive nanocarriers for drug and gene delivery (2015)
18. Current Applications of Gold Nanoparticles for Medical Imaging and As Treatment Agents for Managing Pancreatic Cancer, Macromolecular Research (2018)
19. Functionalised Nanomaterials for Eradication of Cscs, a Promising Approach for Overcoming Tumour Heterogeneity, Journal of Drug Targeting (2018)
20. Magnetic Bio-Metal–Organic Framework Nanocomposites Decorated With Folic Acid Conjugated Chitosan As a Promising Biocompatible Targeted Theranostic System for Cancer Treatment, Materials Science and Engineering C (2019)